SIGLEC1 and acute respiratory distress syndrome: In agreement with this observation, we exclusively found higher expression levels of CD169/SIGLEC1 in mild disease stages but not in severe forms, suggesting that CD169/SIGLEC1 or other interferon-associated downstream mediators are protective in disease progression to ARDS.